Good morning,
In the world of Grand Slam tennis, everything about the U.S. Open has an air of bright lights, big city—and also big numbers.
When the world’s largest tennis tournament kicks off Monday, the sport’s greats won’t just be competing for glory, each player will get a slice of the record $75 million in prize money.
Last year’s champs Coco Gauff and Novak Djokovic will be looking to defend their titles. Doing so would give Djokovic a record-extending 25 Grand Slam championships, and Gauff faces a challenge in this year’s betting favorite Aryna Sabalenka. The competition, held at the USTA Billie Jean King National Tennis Center in Queens, generated $514 million in operating revenue last year.
Fans attending the tournament can quench their thirst with a signature “Honey Deuce,” a cocktail garnished with three honeydew melon balls. More than 450,000 of them were sold last year.
Photo by JOEL SAGET/AFP via Getty Images
The FDA approved Pfizer and Moderna’s new Covid-19 vaccines Thursday, and the drugmakers say the shots will be available in the coming days ahead of an expected respiratory virus surge in the fall and winter. Both shots target the KP.2 variant—a descendant of the omicron subvariant—that was the dominant strain circulating in the U.S. earlier this year, and the CDC recommends that everyone six months and older get an updated vaccine.
Former billionaire Ryan Breslow stunned investors with a plan to raise $450 million for his “one-click” payments startup Bolt at a $14 billion valuation. But the head of the primary investment firm named in the financial documents, Silverbear Capital, claims to never have spoken with Breslow or Bolt.
Shares of Peloton jumped 35% Thursday, its largest single-day percentage gain since going public in 2019, after reporting year-over-year revenue growth for the first time in two years. Still, the company’s market cap is about 97% lower than the all-time high reached during the pandemic, as eased Covid restrictions lowered demand for the company’s at-home exercise bikes.
Major stock indexes had their worst days in weeks ahead of a key speech from Federal........